RT Journal Article
SR Electronic
T1 Polymorphisms affecting expression of the vaccine antigen factor H binding protein influence invasiveness of Neisseria meningitidis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.08.21249443
DO 10.1101/2021.01.08.21249443
A1 Sarah G. Earle
A1 Mariya Lobanovska
A1 Hayley Lavender
A1 Changyan Tang
A1 Rachel M. Exley
A1 Elisa Ramos-Sevillano
A1 Douglas Browning
A1 Vasiliki Kostiou
A1 Odile B. Harrison
A1 Holly B. Bratcher
A1 Gabriele Varani
A1 Christoph M. Tang
A1 Daniel J. Wilson
A1 Martin C. J. Maiden
YR 2021
UL http://medrxiv.org/content/early/2021/01/09/2021.01.08.21249443.abstract
AB Many bacterial diseases are caused by organisms that ordinarily are harmless components of the human microbiome. Effective interventions against these conditions requires an understanding of the processes whereby symbiosis or commensalism breaks down. Here, we performed bacterial genome-wide association studies (GWAS) of Neisseria meningitidis, a common commensal of the human respiratory tract despite being a leading cause of meningitis and sepsis. GWAS discovered single nucleotide polymorphisms (SNPs) and other bacterial genetic variants associated with invasive meningococcal disease (IMD) versus carriage in several loci across the genome, revealing the polygenic nature of this phenotype. Of note, we detected a significant peak around fHbp, which encodes factor H binding protein (fHbp); fHbp promotes bacterial immune evasion of human complement by recruiting complement factor H (CFH) to the meningococcal surface. We confirmed the association around fHbp with IMD in a validation GWAS, and found that SNPs identified in the validation affecting the 5’ region of fHbp mRNA alter secondary RNA structures, increase fHbp expression, and enhance bacterial escape from complement-mediated killing. This finding mirrors the known link between complement deficiencies and CFH variation with human susceptibility to IMD, highlighting the central importance of human and bacterial genetic variation across the fHbp:CFH interface in IMD susceptibility, virulence, and the transition from carriage to disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork in CMT's laboratory is funded by a Wellcome Trust Senior Investigator award. D.J.W. is supported by a Sir Henry Dale Fellowship (Grant 101237/Z/13/B) and a Big Data Institute Robertson Fellowship. Computation using the Oxford Biomedical Research Computing (BMRC) facility is supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. Financial support was provided by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z. Work at the University of Washington was supported by NIH NIGMS 1R35 GM 126942.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable - performed bacterial genome-wide association studies plus functional validation in bacterial strains.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIllumina sequencing reads were downloaded from the European Nucleotide Archive (ENA, http://www.ebi.ac.uk/ena), and Velvet de novo assemblies and phenotypes from PubMLST (https://pubmlst.org/neisseria/). PubMLST IDs, ENA accession numbers and phenotypes can be found in Supplementary Tables 6 and 7.All data, code, and materials used in the analyses can be accessed at:https://github.com/SiyuChenOxf/COVID19SeroModel/tree/master